Immunocore Holdings (IMCR) Enterprise Value (2019 - 2026)

Immunocore Holdings has disclosed Enterprise Value across 8 years of filings, most recently posting -$844.9 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$844.9 million, down 0.94% year-over-year; the trailing twelve-month figure through Mar 2026 was -$844.9 million (down 0.94% YoY), and the FY2025 annual result was -$864.1 million, down 5.34% from the prior year.
• Enterprise Value came in at -$844.9 million for Q1 2026 at Immunocore Holdings, up from -$864.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$390.0 million in Q4 2022 to a low of -$901.3 million in Q3 2024.
• The 5-year median for Enterprise Value is -$844.9 million (2026), against an average of -$778.9 million.
• Across the five-year window, Enterprise Value sank 85.33% in 2024 and gained 0.99% in 2025, its largest moves.
• Immunocore Holdings' Enterprise Value stood at -$390.0 million in 2022, then slipped by 13.48% to -$442.6 million in 2023, then tumbled by 85.33% to -$820.3 million in 2024, then slipped by 5.34% to -$864.1 million in 2025, then advanced by 2.23% to -$844.9 million in 2026.
• The last three Enterprise Value figures came in at -$844.9 million (Q1 2026), -$864.1 million (Q4 2025), and -$892.3 million (Q3 2025), per Business Quant data.